---
figid: PMC5539373__z9j0011727880014
figtitle: Signalling pathways underlying excitation-contraction coupling
organisms:
- Mus musculus
- Homo sapiens
pmcid: PMC5539373
filename: z9j0011727880014.jpg
figlink: /pmc/articles/PMC5539373/figure/F14/
number: F14
caption: Signalling pathways underlying excitation-contraction coupling. β-Adrenergic
  receptor (βAR) activation through stimulatory guanine nucleotide-binding (Gs) proteins
  increases cellular cAMP levels (A). This in turn drives a phosphokinase-A (PKA)-mediated
  phosphorylation and activation of L-type Ca2+ channels and cardiac ryanodine receptor
  (RyR2) SR-Ca2+ release channels (A) and the exchange protein directly activated
  by cAMP (Epac) pathway producing a calmodulin kinase II (CaMKII)-mediated RyR2 activation
  (B). Either action on the Ca2+-induced Ca2+ mechanism impinges on the level of SR
  Ca2+ release (C), and consequent alterations in cytosolic Ca2+ (D). Experimentally
  used agonists (+) and antagonist (−) agents used on these pathways include isoproterenol,
  H-89, 8-pCPT-2-O-Me-cAMP (8-CPT), and KN-93.
papertitle: Murine Electrophysiological Models of Cardiac Arrhythmogenesis.
reftext: Christopher L.-H. Huang. Physiol Rev. 2017 Jan;97(1):283-409.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9431987
figid_alias: PMC5539373__F14
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC5539373__F14
ndex: 1e278851-deb7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5539373__z9j0011727880014.html
  '@type': Dataset
  description: Signalling pathways underlying excitation-contraction coupling. β-Adrenergic
    receptor (βAR) activation through stimulatory guanine nucleotide-binding (Gs)
    proteins increases cellular cAMP levels (A). This in turn drives a phosphokinase-A
    (PKA)-mediated phosphorylation and activation of L-type Ca2+ channels and cardiac
    ryanodine receptor (RyR2) SR-Ca2+ release channels (A) and the exchange protein
    directly activated by cAMP (Epac) pathway producing a calmodulin kinase II (CaMKII)-mediated
    RyR2 activation (B). Either action on the Ca2+-induced Ca2+ mechanism impinges
    on the level of SR Ca2+ release (C), and consequent alterations in cytosolic Ca2+
    (D). Experimentally used agonists (+) and antagonist (−) agents used on these
    pathways include isoproterenol, H-89, 8-pCPT-2-O-Me-cAMP (8-CPT), and KN-93.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Adrb1
  - Bfar
  - gs
  - Gs
  - Rapgef3
  - Camk2a
  - Camk2b
  - Ryr2
  - Ica1
  - Isoproterenol
---
